Skip to main content

Table 5 Multivariate analysis of OS

From: The prognostic role of pre-treatment neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in esophageal squamous cell carcinoma treated with concurrent chemoradiotherapy

Prognostic factors

Overall-Survival

Odds ratio

95% CI

p

NLR

0.539

0.414–0.701

0.000

PLR

0.712

0.548–0.925

0.011

TNM stage

1.481

1.113–1.971

0.007

Tumor length

0.960

0.726–1.271

0.777